The Biotech Growth Trust PLC

BIOG

GB0000385517

Investment Trusts

Market Closed - London S.E. Other stock markets 11:35:10 2024-04-26 am EDT			5-day change	1st Jan Change
937 ^GBX	+1.19%		+0.64%	+4.81%

Mar. 26	Biotech Group Acquisition Withdraws IPO	DJ
2023	Biotech Growth's total return underperforms benchmark in tough market	AN

The Biotech Growth Trust PLC Reports Earnings Results for the Half Year Ended September 30, 2022

November 16, 2022 at 02:00 am EST

The Biotech Growth Trust PLC reported earnings results for the half year ended September 30, 2022. For the half year, the company reported net income was GBP 36.99 million compared to net loss of GBP 49.83 million a year ago. Basic earnings per share from continuing operations was GBP 0.907 compared to basic loss per share from continuing operations of GBP 1.195 a year ago.

Latest news about The Biotech Growth Trust PLC

Biotech Group Acquisition Withdraws IPO	Mar. 26	DJ
Biotech Growth's total return underperforms benchmark in tough market	Nov. 10	AN
The Biotech Growth Trust PLC Reports Earnings Results for the Half Year Ended September 30, 2023	Nov. 09	CI
The Biotech Growth Trust plc Appoints Hamish Baillie to the Board	Nov. 09	CI
The Biotech Growth Trust plc Announces Appointment of Hamish Baillie as Independent Non-Executive Director, Effective from November 1, 2023	23-10-09	CI
Biotech Growth Trust net assets drop after "another difficult year"	23-06-15	AN
Biotech Growth underperforms benchmark	23-06-15	AN
The Biotech Growth Trust PLC Reports Earnings Results for the Full Year Ended March 31, 2023	23-06-15	CI
The Biotech Growth Trust PLC Reports Earnings Results for the Full Year Ended March 31, 2023	23-06-15	CI
EARNINGS SUMMARY: Biotech Growth, Dunedin Enterprise net assets grow	22-11-16	AN
The Biotech Growth Trust PLC Reports Earnings Results for the Half Year Ended September 30, 2022	22-11-16	CI
The Biotech Growth Trust PLC commences an Equity Buyback Plan for 6,134,167 shares, representing 14.90% of its issued share capital, under the authorization approved on July 19, 2022.	22-07-22	CI
The Biotech Growth Trust Plc's Equity Buyback announced on September 10, 2021, has expired.	22-07-19	CI
The Biotech Growth Trust PLC Reports Earnings Results for the Full Year Ended March 31, 2022	22-06-01	CI
The Biotech Growth Trust PLC Reports Earnings Results for the Full Year Ended March 31, 2022	22-06-01	CI
FTSE 100 Slips Over Rising Wages, Gas-Price Concerns	21-11-16	DJ
FTSE 100 Down Despite Gains for Diageo, Vodafone	21-11-16	DJ
The Biotech Growth Trust PLC Announces Directorate Changes	21-11-16	CI
The Biotech Growth Trust PLC Reports Earnings Results for the Half Year Ended September 30, 2021	21-11-11	CI
Tranche Update on The Biotech Growth Trust PLC's Equity Buyback Plan announced on September 10, 2021.	21-11-11	CI
The Biotech Growth Trust PLC commences an Equity Buyback Plan for 6,256,041 shares, representing 14.99% of its issued share capital, under the authorization approved on July 14, 2021.	21-09-10	CI
The Biotech Growth Trust PLC Appoints Nicki Shepherd as a Director of the Company	21-07-14	CI
The Biotech Growth Trust PLC Announces Board Changes	21-07-14	CI
The Biotech Growth Trust plc Reports Earnings Results for the Full Year Ended March 31, 2021	21-06-04	CI
The Biotech Growth Trust PLC Appoints Nicola Shepherd as an Independent Non-Executive Director	21-01-18	CI

Chart The Biotech Growth Trust PLC

Duration

Period

More charts

Company Profile

The Biotech Growth Trust PLC is a United Kingdom-based investment trust. The Company's investment objective is to seek capital appreciation through investment in the biotechnology industry across the world. It invests in a diversified portfolio of shares and related securities in biotechnology companies. The Company invests approximately 10% in aggregate of the value of its gross assets in other closed-ended investment companies, including investment trusts listed on the London Stock Exchange. The Company invests approximately 15% of the value of its gross assets in any one individual stock at the time of acquisition. Its portfolio of investments across various countries includes Netherlands, the United States of America, Canada, and China. The Companyâs alternative investment fund manager is Frostrow Capital LLP.

Sector

Investment Trusts

Calendar

2024-11-13 - Q2 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

9.37

Average target price

Consensus

Sector Investment Trusts

	1st Jan change	Capi.
THE BIOTECH GROWTH TRUST PLC	+4.81%	390M
SCOTTISH MORTGAGE INVESTMENT TRUST PLC	+3.27%	14.32B
F&C INVESTMENT TRUST PLC	+3.12%	6.21B
POLAR CAPITAL TECHNOLOGY TRUST PLC	+12.72%	4.4B
ALLIANCE TRUST PLC	+10.97%	4.36B
GREENCOAT UK WIND PLC	-7.52%	4B
RIT CAPITAL PARTNERS PLC	+3.61%	3.51B
JPMORGAN GLOBAL GROWTH & INCOME PLC	+8.55%	3.22B
THE MONKS INVESTMENT TRUST PLC	+7.91%	3.06B
SMITHSON INVESTMENT TRUST PLC	-1.91%	2.77B

Investment Trusts